460 related articles for article (PubMed ID: 32327996)
1. How Non-invasive
Iafrate M; Fruhwirth GO
Front Physiol; 2020; 11():154. PubMed ID: 32327996
[TBL] [Abstract][Full Text] [Related]
2. Whole-Body Imaging to Assess Cell-Based Immunotherapy: Preclinical Studies with an Update on Clinical Translation.
Sato N; Choyke PL
Mol Imaging Biol; 2022 Apr; 24(2):235-248. PubMed ID: 34816284
[TBL] [Abstract][Full Text] [Related]
3. Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy.
Gosmann D; Russelli L; Weber WA; Schwaiger M; Krackhardt AM; D'Alessandria C
EJNMMI Res; 2022 Jan; 12(1):5. PubMed ID: 35099641
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.
Ashmore-Harris C; Iafrate M; Saleem A; Fruhwirth GO
Mol Ther; 2020 Jun; 28(6):1392-1416. PubMed ID: 32243834
[TBL] [Abstract][Full Text] [Related]
5. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of cellular immunotherapies in experimental and therapeutic settings.
Shalaby N; Dubois VP; Ronald J
Cancer Immunol Immunother; 2022 Jun; 71(6):1281-1294. PubMed ID: 34657195
[TBL] [Abstract][Full Text] [Related]
7. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
8. ImmunoPET: harnessing antibodies for imaging immune cells.
Wu AM; Pandit-Taskar N
Mol Imaging Biol; 2022 Apr; 24(2):181-197. PubMed ID: 34550529
[TBL] [Abstract][Full Text] [Related]
9. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
10. Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET.
Bu L; Sun Y; Han G; Tu N; Xiao J; Wang Q
Curr Pharm Des; 2020; 26(6):675-687. PubMed ID: 31465273
[TBL] [Abstract][Full Text] [Related]
11. Imaging of T-cells and their responses during anti-cancer immunotherapy.
Krekorian M; Fruhwirth GO; Srinivas M; Figdor CG; Heskamp S; Witney TH; Aarntzen EHJG
Theranostics; 2019 Oct; 9(25):7924-7947. PubMed ID: 31656546
[TBL] [Abstract][Full Text] [Related]
12. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
13. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
Ariyasu R; Nishikawa H
Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
[TBL] [Abstract][Full Text] [Related]
14. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal
Jacob J; Nadkarni S; Volpe A; Peng Q; Tung SL; Hannen RF; Mohseni YR; Scotta C; Marelli-Berg FM; Lechler RI; Smyth LA; Fruhwirth GO; Lombardi G
Mol Ther Methods Clin Dev; 2021 Mar; 20():324-336. PubMed ID: 33511246
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.
Gangadaran P; Ahn BC
Front Immunol; 2017; 8():1090. PubMed ID: 28955332
[TBL] [Abstract][Full Text] [Related]
18. The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies.
Fruhwirth GO; Kneilling M; de Vries IJM; Weigelin B; Srinivas M; Aarntzen EHJG
Mol Imaging Biol; 2018 Oct; 20(5):696-704. PubMed ID: 30030697
[TBL] [Abstract][Full Text] [Related]
19. Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy.
Lauwerys L; Smits E; Van den Wyngaert T; Elvas F
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625811
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
